Gene · 51592
Papers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared genetic susceptibility between idiopathic inflammatory myopathies and common B cell lymphoma subtypes found primarily in the human leucocyte antigen region. | RMD Open | 2025 | 40854812 | PubTator, text mining | PubMed |
| Roles of lactylation in lipid metabolism and related diseases. | Cell Death Discov | 2025 | 40849305 | PubTator, text mining | PubMed |
| Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive Therapy. | Antibodies (Basel) | 2025 | 40843675 | PubTator, text mining | PubMed |
| LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation. | Cell Signal | 2025 | 40834976 | PubTator, text mining | PubMed |
| Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights. | Clin Rev Allergy Immunol | 2025 | 40824431 | PubTator, text mining | PubMed |
| Ulcerative Holster Sign in Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis. | J Clin Rheumatol | 2025 | 40815808 | PubTator, text mining | PubMed |
| TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer. | Proc Natl Acad Sci U S A | 2025 | 40815626 | PubTator, text mining | PubMed |
| Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2025 | 40809696 | PubTator, text mining | PubMed |
| Pulmonary Involvement in Patients with Positive Myositis Antibodies in Rheumatology: A Retrospective Monocentric Analysis. | J Clin Med | 2025 | 40807061 | PubTator, text mining | PubMed |
| An ancient enhancer rapidly evolving in the human lineage promotes neural development and cognitive flexibility. | Sci Adv | 2025 | 40802760 | PubTator, text mining | PubMed |
| Robot-assisted surgery for rectal cancer with tumor-associated dermatomyositis during preoperative chemotherapy: A case report and literature review. | Medicine (Baltimore) | 2025 | 40797474 | PubTator, text mining | PubMed |
| Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region. | Rheumatology (Oxford) | 2025 | 40795062 | PubTator, text mining | PubMed |
| Erythematous Follicular Papules on the Thighs: A Quiz. | Acta Derm Venereol | 2025 | 40787741 | PubTator, text mining | PubMed |
| Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment. | Semin Immunopathol | 2025 | 40770118 | PubTator, text mining | PubMed |
| Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis. | Sci Rep | 2025 | 40759686 | PubTator, text mining | PubMed |
| Clinical Profile and Outcomes in Anti-TIF1γ Positive Idiopathic Inflammatory Myositis Patients: A Greek Cohort Study. | Mediterr J Rheumatol | 2025 | 40757129 | PubTator, text mining | PubMed |
| Exploring the zinc-binding proteins in the mutational hotspots of human cancer. | J Trace Elem Med Biol | 2025 | 40752378 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER. | Front Oncol | 2025 | 40746607 | PubTator, text mining | PubMed |
| TRIM21: a multifaceted regulator in cancer. | Front Cell Dev Biol | 2025 | 40735642 | PubTator, text mining | PubMed |
| The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review. | Cancers (Basel) | 2025 | 40723250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51592/papers?page=6